RNF138 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.162780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.332600E-01
Normal-vs-Stage2
1.152180E-01
Normal-vs-Stage3
1.102380E-02
Normal-vs-Stage4
1.779830E-01
Stage1-vs-Stage2
7.768600E-01
Stage1-vs-Stage3
1.213370E-01
Stage1-vs-Stage4
9.604800E-01
Stage2-vs-Stage3
1.598960E-01
Stage2-vs-Stage4
7.750800E-01
Stage3-vs-Stage4
3.418200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.425900E-02
Normal-vs-AfricanAmerican
5.816200E-01
Normal-vs-Asian
3.255200E-01
Caucasian-vs-AfricanAmerican
1.650810E-01
Caucasian-vs-Asian
9.084000E-01
AfricanAmerican-vs-Asian
4.083400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.598100E-02
Normal-vs-Female
2.280600E-01
Male-vs-Female
1.077380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.634200E-02
Normal-vs-Age(41-60Yrs)
1.555630E-01
Normal-vs-Age(61-80Yrs)
1.103960E-01
Normal-vs-Age(81-100Yrs)
2.224400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.858800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.148400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.837800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.647030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.473200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.736400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.882020E-03
Normal-vs-Daily Drinker
1.396240E-01
Normal-vs-Weekly Drinker
5.538300E-03
Normal-vs-Occasional Drinker
1.423640E-01
Normal-vs-Social Drinker
5.547800E-01
Non Drinker-vs-Daily Drinker
4.289200E-01
Non Drinker-vs-Weekly Drinker
8.466000E-01
Non Drinker-vs-Occasional Drinker
1.023560E-01
Non Drinker-vs-Social Drinker
1.196950E-01
Daily Drinker-vs-Weekly Drinker
3.934800E-01
Daily Drinker-vs-Occasional Drinker
5.624000E-01
Daily Drinker-vs-Social Drinker
2.907800E-01
Weekly Drinker-vs-Occasional Drinker
1.239030E-01
Weekly Drinker-vs-Social Drinker
1.121200E-01
Occasional Drinker-vs-Social Drinker
5.426000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.190600E-01
Normal-vs-Grade 2
4.110200E-01
Normal-vs-Grade 3
4.960400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.653900E-02
Grade 1-vs-Grade 3
4.317600E-02
Grade 1-vs-Grade 4
3.190600E-01
Grade 2-vs-Grade 3
6.050600E-01
Grade 2-vs-Grade 4
4.110200E-01
Grade 3-vs-Grade 4
4.960400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.966400E-02
Normal-vs-NonDiabetic
9.470200E-02
Diabetic-vs-NonDiabetic
7.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.399620E-01
Normal-vs-NoPancreatitis
9.398000E-02
Pancreatitis-vs-NoPancreatitis
2.980600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.184210E-01
Normal-vs-N1
1.319950E-01
N0-vs-N1
5.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.089800E-02
Normal-vs-TP53-NonMutant
3.684800E-01
TP53-Mutant-vs-TP53-NonMutant
6.377800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
